The impact of histone phosphorylation, acetylation, and methylation onto transcription and various other cellular DNA-mediated processes is now well established. Numerous histone modification marks, specific sites carrying particular post-translational modifications, have been described and analyzed in detail. Whereas, many methods for the study of histone post-translational modifications involve sophisticated equipment and techniques, we describe the revival of a very simple procedure for the analysis of histone modifications and histone modifying enzymes, which is derived from experiments first carried out several decades ago. This method is based on the isolation of cell nuclei containing intact chromatin structures that are then incubated with defined enzymatic substrates of histone modifying enzymes. We provide quick protocols for the isolation of nuclei from yeast and mammalian cells and give basic procedures for the phosphorylation, acetylation, and methylation of histones (and other proteins) using these subcellular sources that can be carried out in any laboratory. Simple methods for the analysis of histone modifications using these assays are discussed.
Introduction
Dynamic changes in the local and global organization of chromatin are emerging as key regulators of genomic function. Indeed, post-translational modifications of histones, the main protein component of chromatin, have become of great biological interest. Histones function as acceptors for a variety of post-translational modifications, including acetylation, methylation and ubiquitination of lysine (K) residues, phosphorylation of serine (S) and threonine (T) residues, and methylation of arginine (R) residues. Correlations between specific histone modifications and several biological processes have become evident, and to date, numerous post-translational modification marks of histones have been analyzed in detail [1, 2] .
Generally, the study of post-translational histone modification can be divided into in vivo experimentation and in vitro analyses. The in vivo approaches make use of classical metabolic isotope labeling techniques for the study and identification of histone marks [3] . More recently, proteomic mass spectrometry-driven approaches have also been deployed, which aided in the discovery of a large number of novel modification marks [4, 5] . In vivo studies of histone modification marks have benefited tremendously form the development of modification mark specific antibodies, which have become available for multiple types of modifications and sites [6, 7] . In vitro experiments, in contrast, rely on purified or recombinant components of enzyme systems that modify histones governing the addition or removal of modification marks as well as the availability of defined enzyme substrates [8] . Historically, histone modifications were first discovered and analyzed in cell free ''in nucleo'' systems [9] [10] [11] [12] . Whereas, these simple experimental approaches have been forgotten for a long time, they can still be quite useful in the study of histone modifications and modifying activities [13] . They can supplement the in vivo and in vitro methods and partially overcome some of the limitations of purely in vivo and in vitro approaches. In nucleo experiments have been revived and refined in our laboratory as they allow for the analysis of histone modification in a native chromatin context while being easily accessible and fast-especially when combined with modern analytical techniques.
The method
The extremely simple outline of in nucleo experiments is summarized in Fig. 1 . Nuclei can be prepared from various eukaryotic cell types, originating from different organisms, at distinct cellular stages (i.e., cell differentiation, cell cycle, etc.), and after various physiological and non-physiological stimuli (i.e., transduced cells, transfected cells, ionized cells, cells with induced DNA breaks, etc.). Isolated nuclei are incubated with (typically) isotopically labeled substrates donating activated phosphate-(ATP), acetyl-(acetyl-CoA), or methyl-(S-adenosylmethionine) groups. Modification of histones (and other proteins) can then be qualitatively analyzed by one-or two-dimensional gel electrophoresis combined with autoradiography. Due to their abundance and extremely basic nature, histones can easily be enriched from the nuclei by acid extraction. Usually, histones recovered after acid extraction and gel electrophoresis are sufficiently pure for further analysis. (i.e., mass spectrometry, Edman degradation). For example, quantitative analysis of modification of a certain site can be achieved by a combination of Edman degradation and scintillation counting [13] . Highly pure histones of different subtypes can be prepared by HPLC reversed phase chromatography of the acid extracts on C4 or C8-resins [14] . Indeed, we have used the in nucleo labeling method to prepare defined substrates for the study of histone de-modifying enzymatic activities (i.e., phosphatases, deacetylases, demethylases; for example see Fig. 2 ).
Isolation of cell nuclei
Detailed, but simple and fast protocols for the isolation of nuclei from yeast and mammalian cells-major sources of study in our laboratory-are provided. Methods for the isolation of nuclei from other sources can be found in the general literature (see for example [15] ).
Notes: Inhibitors of proteases and phosphatases or deacetylases are added to various buffers used in the following protocols.
Protease inhibitors: Complete (Roche), or similar broad band inhibitor cocktails (SIGMA); alternatively, the following combination of inhibitors can be used: 20 lg/ml chymostatin (Roche; stock, 20 mg/ml in 
DMSO); 1 lg/ml peptstatin A (Roche; stock, 1 mg/ml in ethanol); 1 lg/ml leupeptin (Roche; stock, 1 mg/ml in H 2 O); 2 lg/ml aprotinin (Roche; stock, 10 mg/ml in H 2 O); 0.5 mM PMSF (SIGMA; stock, 100 mM in ethanol); 2 mM benzamidine-HCl (SIGMA; stock, 1 M in H 2 O); store all inhibitor stock solutions at À20°C.
Phosphatase inhibitors: we routinely use 1 lM microcystin LR (Calbiochem; stock, 1 mM in DMSO; store at À20°C) in phosphorylation in nucleo experiments. The following buffer additions, alone or in combination, might also be useful to inhibit serine/threonine phosphatases in these assays: 5 mM Na 4 P 2 O 7 (Sodiumpyrophosphate); 50 mM NaF; 10 mM b-glyerophosphate.
Deacetylase inhibitor: 400 nM trichostatin A (SIG-MA; stock, 1 mM in DMSO; store at À20°C). nuclei can be achieved by re-extracting the pellet of step 7 with the supernatant of the high-speed centrifugation (Dounce homogenization). 9. Overlay nuclei suspension on 2 ml of CP buffer and centrifuge 4°C, 30 min, 30,000g. 10. Re-suspend nuclei in NP buffer (at ca. 1-3 · 10 9 cells/ml). Use nuclei immediately or freeze in liquid N 2 and store at À80°C until further use.
Notes: We routinely grow 1-2 l cultures to obtain a significant number of yeast cells for the preparation of nuclei according to this protocol. As an alternative to zymolase, yeast lytic enzyme (ICN) at 5 mg/ml can be used for spheroplasting (step 4). 
Collect nuclei by centrifugation (4°C, 10 min, 600g).
Wash nuclei once in buffer III. 5. Re-suspend nuclei in buffer III (at %1 · 10 8 cells/ml). Use nuclei immediately or freeze in liquid N 2 and store at À80°C until further use.
Notes: Nuclei prepared by other methods, for example, the classical protocol according to Dignam et al. [16] can also be used. However, different preparation methods, may lead to varying results and labeling efficiencies from the same batch of cells since enzymes can be inactivated or washed out of the nuclei under conditions of high (> 500 mM total ionic strength) or low (< 10 mM total ionic strength) salt. Optionally, nuclei can be further purified by centrifugation through a sucrose cushion. Resuspend nuclei (at %1 · 10 7 cells/ml) in buffer I containing 0.25 M sucrose and overlay on a cushion of 2 ml buffer I containing 2.3 M sucrose. Pellet nuclei through the density cushion by centrifugation, 4°C, 60 min, 1,00,000g. Proceed according to step 4. An alternative formulation of buffer III contains 0.25 M sucrose instead of 20% (v/v) glycerol.
In nucleo labeling reactions
The number of nuclei used in the provided protocols is for mammalian cell lines. When nuclei form other cellular sources are to be used, adjust the number of nuclei according to the nuclear content of these cells (i.e., routinely we use 10· more nuclei from yeast cells in our in nucleo reactions when comparing modifying activities from yeast and human cells). Notes: Boiling nuclei directly in Laemmli SDS loading buffer (increased boiling times (> 5 min) are recommended) often results in very viscous solutions that cannot be loaded onto SDS-PAGE gels. Shear genomic DNA by pushing solution 20· through a 27 g needle. Notes: When working with yeast nuclei, wash nuclei three times with 10 mM Tris-HCl (pH 8.0), 75 mM NaCl, protease and phosphatase inhibitors (at ca. 5 · 10 8 cells/ml). Then resuspend nuclei in 10 mM Tris-HCl (pH 8.0), 400 mM NaCl, protease and phosphatase inhibitors (at ca. 1 · 10 9 cells/ml). Gradually add 4 N H 2 SO 4 to a final concentration of 0.4 N. Proceed with histone extraction as described.
Alternatively to the precipitation of total protein with TCA, core histones (H2A, H2B, H3, and H4) can be precipitated more selectively by the addition of perchloric acid (PCA) to 5.4% (v/v) final to the acid soluble fraction (step 2). Linker histones of the H1 type and basic HMG proteins are soluble under these conditions and will therefore be separated from core histones. After centrifugation and recovery of the precipitated core histones, histone H1, and HMG proteins can be collected after precipitation with 20% (v/v) TCA.
Concluding remarks
In nucleo experiments in essence similar to the procedures described here were used frequently during the initial discovery of histone modifications [9] [10] [11] [12] . Over the years these simple methods have been more and more overlooked and were substituted by cellular labeling experiments. Neither, ATP, nor Acetyl-CoA, nor SAM is cell-permeable. Ortho-phosphate, acetate, leucine, or methyl-methionine [17, 18] are taken up by various cell types (yeast cells have to be spheroplasted to achieve good uptake) and are intracellularly converted to ATP, Acetyl-CoA, and SAM, respectively. However, labeling efficiencies of cellular labeling reactions are often rather low. In nucleo reactions can offer a very effective and cost saving alternative as nuclei in the described procedures can be highly concentrated and are easily penetrated by the substrates ATP, Acetyl-CoA, and SAM [13] .
A so far very little exploited area of in nucleo assays concerns the modification of nuclear proteins other than histones by phosphorylation, acetylation, or methylation. Obviously, other-yet unknown-proteins can become modified by the same or different enzymatic activities that are targeting histones in these reactions (see Fig. 2 ). In addition, the study of post-translational modification(s) of defined but less abundant nuclear proteins should be accessible in in nucleo experiments. We have just started to exploit this area by using nuclei from cells that have been engineered to overexpress (for example, by transfection) defined factors that contain immuno-affinity tags (such as FLAG-and/or HA-tags) for ready identification and purification.
